Andrew Hsieh

18PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiological network analysisCell metabolismCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 16, 2026
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes.

|Aug 13, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.

|Mar 31, 2026
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.

Alireza Ghodsi, Lukas Owens, Ridvan Arda Demirci

|Aug 06, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.

Hyun Jung Lee, Roman Gulati, Erolcan Sayar

|May 29, 2025
Decoding post-transcriptional regulatory networks by RNA-linked CRISPR screening in human cells.

Patrick J Nugent, Heungwon Park, Cynthia L Wladyka

|Nov 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz

Pageof 3

Frequent Collaborators

6 joint publications

Peter S Nelson

5 joint publications

Sonali Arora

4 joint publications

Petros Grivas

4 joint publications

Roman Gulati